Radiopharmaceutical supplies
Ended Purchase Order Awarded Last action
- Contract number
- N6809522P0012
- Awardee
-
RLS (USA) Inc. UEI UA3GDUKRYSM5
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $33,891
Award facts
- Opportunity
-
- Radiopharmaceutical Special Notice · N6809522Q0012 · Posted Apr 8, 2022
- Contract value 66% obligated
-
- $33,890.92 Current, with exercised options
- $51,390.92 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Tampa, FL 33614, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$26,109 | |
| Exercise an Option | $30,000 | |
| Original award | $30,000 |
About this award
This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, for the supply of radiopharmaceutical products. The contract has a ceiling value of $51,390.92 and a period of performance through December 31, 2024.
The award is for the provision of critical radiopharmaceuticals, such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate (NETSPOT), which are used in nuclear medicine diagnostic services at government healthcare facilities, primarily the Department of Veterans Affairs (VA) and military treatment facilities.
RLS (USA) Inc. is an established federal contractor, holding numerous Indefinite Delivery Vehicles (IDVs) with the VA and DHA for radiopharmaceutical supplies, with ceiling values ranging from $250,000 to nearly $5 million. This specific award was made through a sole source justification under FAR 6.302-1, as the government determined RLS (USA) Inc. was the only responsible source able to meet the requirement.
Quick answers
Who was awarded contract N6809522P0012?
N6809522P0012 was awarded to RLS (USA) Inc. by Defense Health Agency (Department of Defense) on May 11, 2022.
How much is contract N6809522P0012 worth?
The government has obligated $33,891 on N6809522P0012. Its potential value, with all options, is $51,391.
Was contract N6809522P0012 competed?
The extent of competition for N6809522P0012 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award